Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

“These results reinforce our resolute development of our nation’s most valuable resource, our young people. They also provide proof that we are undoing apartheid’s planned legacy of intergenerational ...